Improve gait and balance remotely
- Trial ID
- NCT06052280
- Official Title
- Management of Initial Parkinson's Disease: a Prospective, Mono-centric, no Profit Pilot Clinical Trial Comparing Conventional Face-to-face Physiotherapy and Home-based Telerehabilitation
- Goal
- Improve gait and balance remotely
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Azienda Sanitaria Locale CN1 Cuneo
- Study Type
- INTERVENTIONAL
- Enrollment
- 40 participants
- Conditions
- Parkinson Disease
- Interventions
- Telerehabilitation exercise program, Home self-exercise program
Summary For Families
The goal is to see if home-based, therapist-led telerehabilitation can match or improve early Parkinson's management for mobility, balance and daily function compared with conventional physiotherapy or a self-directed home program. The telerehab arm delivers live, video-guided exercise sessions with real-time feedback and progression from a physiotherapist, while the home arm follows a prescribed self-exercise plan; both focus on strength, gait and balance and are meant to complement, not replace, medications like levodopa by helping you move better on your current drug regimen. The trial is looking for adults 18 and older with idiopathic Parkinson's at early stages (Hoehn and Yahr stage 2 or below), a MoCA score above 25, ability to consent and participate, and for the telerehab arm reliable home internet and about 2 meters of clear space in front of a device. People with atypical Parkinsonism or serious medical problems that would limit moderate exercise are excluded.
Locations
- Azienda Sanitaria Locale CN1, Cuneo, Italy
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Telerehabilitation exercise program. The goal is to see if home-based, therapist-led telerehabilitation can match or improve early Parkinson's management for mobility, balance and daily function compared with conventional physiotherapy or a self-directed home program. The telerehab arm delivers live, video-guided exercise sessions with real-time feedback and progression from a physiotherapist, while the home arm follows a prescribed self-exercise plan; both focus on strength, gait and balance and are meant to complement, not replace, medications like levodopa by helping you move better on your current drug regimen. The trial is looking for adults 18 and older with idiopathic Parkinson's at early stages (Hoehn and Yahr stage 2 or below), a MoCA score above 25, ability to consent and participate, and for the telerehab arm reliable home internet and about 2 meters of clear space in front of a device. People with atypical Parkinsonism or serious medical problems that would limit moderate exercise are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.